Stock Track | IPG Photonics Plummets 5.62% as Q4 Results Disappoint and 2025 Outlook Falls Short

Stock Track
11 Feb

Shares of IPG Photonics Corporation (IPGP) plunged 5.62% on Tuesday during the intraday trading session, following the company's disappointing fourth-quarter 2024 financial results and weaker-than-expected guidance for the first quarter of 2025.

The fiber laser manufacturer reported a 21.6% year-over-year decline in revenue to $234.3 million for the fourth quarter, although this figure slightly surpassed analysts' estimates. However, earnings per share of $0.18 missed expectations of $0.21, representing a significant drop from the prior year's $0.89 EPS.

IPG Photonics attributed the revenue decline to lower sales in its core materials processing and medical applications segments, reflecting challenging demand conditions in the global industrial market. The company's CEO, Dr. Mark Gitin, acknowledged the difficult environment and emphasized the company's focus on managing costs and investing in strategic growth initiatives.

Looking ahead, IPG Photonics provided revenue guidance for the first quarter of 2025 in the range of $210 million to $240 million, falling short of analysts' expectations of $234.4 million. The company also guided for adjusted earnings per share between $0.05 and $0.35, missing the consensus estimate of $0.35.

The disappointing results and outlook, coupled with the announcement of a leadership change in the sales and marketing division, weighed heavily on investor sentiment, leading to the stock's sharp decline on Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10